Oncology Industry Taskforce

In Sydney, InGeNA CEO Dr. Erin Evans joined the Oncology Industry Taskforce for its first meeting of 2025 as a guest speaker.  Sharing InGeNA’s vision for driving change in precision oncology – where innovative, personalised medicine can deliver better outcomes for patients. Now is the time to ensure rapid, predictable, and equitable access to world-class cancer treatments. 

Partnerships between industry and government have never been more important. At InGeNA, we are committed to working with key stakeholders to shape policies and funding settings that reflect the full value of these innovations. A huge thank you to co-chairs Heather Cahill and Katrina Vanin for the opportunity to engage with industry leaders, and to Sarojini Balkrishna for hosting us. The discussion was highly engaged, and we look forward to continuing these critical conversations.